The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
Open accessAbstract
Overexpression of the HER2 / Neu protooncogene has been linked to the progression of breast cancer. Here we demonstrate that the growth of prostate cancer LNCaP cells can also be increased by the stable transfection of HER2 / Neu . Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level. Reporter assays and mammalian two-hybrid assays further suggest this HER2/Neu-induced androgen receptor (AR) transactivation may function through the promotion of interaction between AR and AR coactivators, such as ARA70. Furthermore, we found this HER2/Neu → MAP kinase → AR-ARAs → PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer. Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 902
Self-citationExpression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.
Press, M. F., Cordon‐Cardo, C., & Slamon, D. J. (1990) · PubMed · Cited by 638
Yeh, S., & Chang, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5517 · Cited by 623
Self-citationActivation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
Androgen Receptor: An Overview
Chang, C., Saltzman, A., Yeh, S., Young, W., Keller, E., Lee, H.-J., Wang, C., & Mizokami, A. (1995) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v5.i2.10 · Cited by 333
Self-citationAlessi, D. R., Smythe, C., & Keyse, S. M. (1993) · PubMed · Cited by 304
Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate
Fujimoto, N., Yeh, S., Kang, H.-Y., Inui, S., Chang, H.-C., Mizokami, A., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8316 · Cited by 294
Self-citationRequirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
Qiu, Y., Ravi, L., & Kung, H.-J. (1998) · Nature · doi:10.1038/30012 · Cited by 280
From estrogen to androgen receptor: A new pathway for sex hormones in prostate
Yeh, S., Miyamoto, H., Shima, H., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5527 · Cited by 267
Self-citationKang, H.-Y., Yeh, S., Fujimoto, N., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8570 · Cited by 230
Self-citationA tyrosine kinase profile of prostate carcinoma.
Robinson, D., He, F., Pretlow, T., & Kung, H. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5958 · Cited by 207
Expression of the c‐erb B‐2 protein in normal and transformed cells
Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B., & Waterfield, M. D. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400221 · Cited by 197
Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
Ikonen, T. (1994) · Endocrinology · doi:10.1210/en.135.4.1359 · Cited by 187
Identification of three proline-directed phosphorylation sites in the human androgen receptor
Zhou, Z. X. (1995) · Molecular Endocrinology · doi:10.1210/me.9.5.605 · Cited by 186
Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic Carcinoma
Kuhn, E. J., Kurnot, R. A., Sesterhenn, I. A., Chang, E. H., & Moul, J. W. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35799-3 · Cited by 158
[29] Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf
Alessi, D. R., Cohen, P., Ashworth, A., Cowley, S., Leevers, S. J., & Marshall, C. J. (1995) · Methods in Enzymology · doi:10.1016/s0076-6879(95)55031-3 · Cited by 158
Myers, R. B., Srivastava, S., Oelschlager, D. K., & Grizzle, W. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1140 · Cited by 158
Δ 5 -Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells
Miyamoto, H., Yeh, S., Lardy, H. A., Messing, E. M., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11083 · Cited by 147
Self-citationA novel splice variant ofHER2 with increased transformation activity
Kwong, K. Y., & Hung, M. (1998) · Molecular Carcinogenesis · Cited by 139
Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J. W., Hsiao, P., Wang, C., Su, C.-Y., & Chang, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8974 · Cited by 135
Self-citationHydroxyflutamide may not always be a pure antiandrogen
Yeh, S., Miyamoto, H., & Chang, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61756-4 · Cited by 68
Self-citationInnovative approaches to the hormonal treatment of advanced prostate cancer.
Trachtenberg, J. (1997) · PubMed · Cited by 12
Research works printed but not linked: 14
- A L Harris, S Nicholson, R Sainsbury, C Wright, J Farndon J Natl Cancer Inst Monogr 11, 181–187 (1992).
- 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O · doi:10.1002/(sici)1098-2744(199810)23:2<62::aid-mc2>3.0.co;2-o
- M F Press, C Cordon-Cardo, D J Slamon Oncogene 5, 953–962 (1990).
- R A Sikes, L W Chung Cancer Res 52, 3174–3181 (1992).
- S J Miller, M C Hung Oncol Rep 2, 497–503 (1995).
- 10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0 · doi:10.1002/(sici)1097-0215(19961021)69:5<398::aid-ijc8>3.0.co;2-0
- J Trachtenberg Eur Urol 32, Suppl. 3, 78–80 (1997).
- Z X Zhou, J A Kemppainen, E M Wilson Mol Endocrinol 9, 605–615 (1995).
- 10.1210/endo.135.4.7925097 · doi:10.1210/endo.135.4.7925097 · Paper page
- Z Culig, A Hobisch, M V Cronauer, C Radmayr, J Trapman, A Hittmair, G Bartsch, H Klocker Cancer Res 54, 5474–5478 (1994).
- 10.1200/JCO.1995.13.5.1129 · DOI
- 10.1016/0046-8177(91)90159-M · doi:10.1016/0046-8177(91)90159-m
- S Yeh, H Miyamoto, H Shima, C Chang Proc Natl Acad Sci USA 95, 5524–5532 (1998).
- D R Alessi, C Smythe, S M Keyse Oncogene 8, 2015–2020 (1993).
Cited by
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Self-citationThe extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
Yoon, S., & Seger, R. (2006) · Growth Factors · doi:10.1080/02699050500284218 · Cited by 1,273
Carver, B. S., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V. K., Le, C., Koutcher, J., Scher, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.008 · Cited by 1,198
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Metadata
- Authors
- Yeh, S., Lin, H.-K., Kang, H.-Y., Thin, T. H., Lin, M.-F., & Chang, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-05-11
- Volume
- 96
- Issue
- 10
- Pages
- 5458-5463
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1985827132
- Cited by
- 594
- References
- 27
- FWCI
- 39.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.